Pain Management: Opioids

Pain Management: Opioids

Dispensing dentists: Warning notice required on opioid prescription labels
04/22/2019
A new state law effective Jan. 1, 2019, requires all dispensers of opioids to prominently display a notice on the prescription label or container of any prescription drug containing an opioid. The notice should be displayed by way of a flag or other notification mechanism attached to the container and must state: “Caution: Opioid. Risk of overdose and addiction.”
Register for March 14 webinar 'EHRs and the Opioid Crisis'
03/11/2019
A monthly webinar series hosted by the California Health Information Partnership & Services Organization continues March 14 with “EHRs and the Opioid Crisis.” The 1.5-hour webinar will summarize the recommendations of a report, “CDC Opioid Guideline: Implementation Guide for Electronic Health Records,” published last November by the Electronic Health Record Association.
CDA Journal spotlights opioid misuse
03/01/2019
The March issue of the Journal of the California Dental Association discusses opioid misuse and provides important concepts of substance-use disorders, pain management and prescription-medication diversion that dentists should consider. A comprehensive caries management guide for dental professionals to use in clinical settings will be included with the issue.
TDIC's informed consent form helps dentists follow law when prescribing opioids to minors
02/06/2019
The Dentists Insurance Company has developed a resource to help prescribers follow a new requirement when prescribing Schedule II drugs to minors. Beginning Jan. 1, 2019, before a prescriber issues the first prescription to a minor for a controlled substance containing an opioid, the prescriber must discuss specific information with the minor or the minor’s parent or guardian. The new form, “Consent to Prescribe an Opioid to a Minor,” covers the required discussion items.
New opioid policy furthers CDA's efforts to reduce abuse, misuse
02/04/2019
Providing education, promoting evidence-based acute pain management practices and forming partnerships with specialty dental organizations form the basis of the CDA Opioid Policy adopted by the CDA House of Delegates at its annual meeting last November. The new policy solidifies CDA’s role as a leader in state health care policy and creates new opportunities to collaborate with health care colleagues and others to reduce the misuse and abuse of prescription opioids.
New opioid laws will affect dentistry in 2019 and beyond
10/31/2018
Many bills were introduced over the past year to combat the opioid epidemic in California, as CDA previously reported. Here is an overview of CDA-supported legislation in the areas of e-prescribing, informed consent, interstate data sharing and prescription-pad requirements, that Gov. Jerry Brown signed into law in September and how these bills will affect the practice of dentistry.
End first exposure: Dentistry's biggest opportunity in the opioid crisis
10/24/2018
Sometimes you read a research article and it hits you between the eyes like a sledgehammer. So it was when I read “Prescription Opioids in Adolescence and Future Opioid Misuse” published in the journal Pediatrics in 2015. It made me really reconsider the impact dentists can have on ameliorating the opioid crisis.
Opioids in California: What is CDA doing?
10/05/2018
CDA began addressing opioids more than three years ago, but the data and countless personal stories tell us that now is a good time to pull together all our resources and efforts and provide our membership with a 360-degree look at the issue in California and CDA’s leadership on it.
Rethinking pain management in our dental practices
09/27/2018
Dentists do a good job managing acute, short-term pain and dentists are not the primary prescribers of opioid analgesics for adults. However, we perform a lot of dental surgeries that result in a lot of opioid prescriptions, and we prescribe the majority of opioid analgesics for children ages 11 to 18. Let’s take a closer look at acute pain management and why it’s time to change our behavior.
Special edition of CDA Update addresses nationwide opioid epidemic
08/30/2018
The September 2018 issue of the Update, CDA’s monthly news magazine, focuses entirely on the opioid crisis gripping America and on dentistry’s leadership role in this crisis. Articles include “Rethinking pain management in our dental practices,” by Solomon Poyourow, DDS, MD, MPH, and “End first exposure: Dentistry’s biggest opportunity in the opioid crisis” by Kerry K. Carney, DDS, CDE. Other articles discuss legislative efforts to curb opioid abuse, alternatives to opioids for managing pain and instructions for prescribing controlled substances electronically.
Encourage patients to 'take them back' to help prevent addiction, overdose
08/15/2018
The next DEA National Prescription Drug Take Back Day is set for Saturday, Oct. 27, and more than 300 locations in California are prepared to help people dispose of unused prescription drugs safely and anonymously. Health care providers can encourage their patients and others to dispose of prescription drugs from 10 a.m. to 2 p.m. Patients should also be made aware that they can also dispose of unused prescription drugs year-round at designated locations.
July 19 webinar will address the opioid crisis, prescribing trends
07/16/2018
A free lunchtime webinar on Thursday, July 19, will examine the current state of the nation’s opioid crisis, including deaths from prescription and illicit opioids, prescribing trends and some of the efforts being made to address the crisis. The one-hour webinar is hosted by the ADA and presented by Dr. Scott Winiecki, team lead for the Food and Drug Administration’s Safe Use Initiative.
CDA-supported bills modify opioid prescribing, CURES requirements
06/07/2018
At least 130 bills to combat the nation’s opioid epidemic have been introduced in U.S. Congress since January, and California is mounting its own legislative efforts to curb opioid abuse. CDA has identified 19 bills in the current session that can be classified into five main categories of opioid legislation. Among these, CDA is taking an official support position on five bills and a support if amended position on a sixth. A summary of the bills and how they may impact the way dentists practice and prescribe follows.
Pain management for adolescents discussed in June 7 ADA webinar
06/04/2018
Because of the growing crisis from illicit and prescription opioid abuse, dentists and other practitioners treating acute pain must understand the risks and benefits of prescribing opioid analgesics such as hydrocodone and oxycodone for managing acute postoperative pain. A free webinar Thursday, June 7, at 8 a.m. PST will address concerns about managing pain when treating adolescents in the dental practice.
Mandatory checks in CURES take effect Oct. 2
04/19/2018
The Department of Justice announced that California’s Controlled Substance Utilization Review and Evaluation System, also known as CURES 2.0, is ready for statewide use and that mandatory CURES consultation becomes effective Oct. 2, 2018. Beginning on this date, prescribers must check a patient’s prescription history in CURES 2.0 before prescribing a Schedule II-IV substance, with some exceptions.
Legislation, CDA Presents lecture, address prescription opioid abuse and CURES
04/16/2018
On the legislative front, in California alone, more than two dozen bills that address opioid prescription and misuse are working their way through the Legislature, including several by Assemblymember Jim Wood, DDS. Meanwhile, CDA continues to provide education and resources on opioid prescribing to members and dentists throughout California. In May at CDA Presents The Art and Science of Dentistry in Anaheim, CDA Public Affairs will host “Clinical and Legal Considerations for Prescribing Controlled Substances.”
ADA advances national policy to reduce opioid dependency
03/28/2018
The ADA on March 26 adopted a new policy to combat the opioid epidemic, calling it the potential first of its kind by a major health professional organization to support mandates on opioid prescription limits and continuing education. “I call upon dentists everywhere to double down on their efforts to prevent opioids from harming our patients and their families,” said ADA President Joseph P. Crowley, DDS, in a press release. The Interim Board Policy on Opioid Prescribing addresses continuing education, dosage and duration, and prescription and drug monitoring.
Dentists with DEA numbers must be registered with CURES 2.0
02/21/2018
“All health care practitioners authorized to prescribe or dispense Schedule II-IV controlled substances were required to register to use CURES 2.0 no later than July 1, 2016,” the Dental Board of California reminds dentists in an email distributed late January. California’s Controlled Substance Utilization Review and Evaluation System aids prescribers and dispensers in identifying fraudulent activity and is intended to reduce prescription drug abuse and diversion.
Resources for dentists as opioid crisis declared public health emergency
11/13/2017
With the U.S. Department of Health and Human Services on Oct. 26 declaring the opioid crisis a public health emergency, CDA reminds dentists, who prescribe approximately 11 percent of prescription opioids annually, of the resources available to them. CDA’s online opioid resource guide at cda.org/opioid is regularly updated with links to resources as they are published.
CVS Health expands fight against opioid abuse
10/25/2017
CVS Health launched a new initiative in September to help fight the national opioid abuse epidemic by enhancing opioid utilization management, providing drug disposal kiosks nationwide and aiding local communities in treatment and recovery services. The president and CEO of CVS Health said in a news release that addressing the nation’s opioid crisis calls for a multipronged effort involving many health care stakeholders, including dentists.
Policy statement on opioid abuse adopted by dental board
10/10/2017
In California alone, opioid-related deaths from 2002 to 2014 were up almost 30 percent, and dentists prescribe up to 12 percent of all opioid prescriptions in the U.S. In light of these alarming statistics, the Dental Board of California in August 2017 finalized and adopted a policy statement recognizing the epidemic of opioid abuse in the U.S.
CURES 'red flags' covered in San Francisco course
07/18/2017
Dentists prescribe approximately 11 percent of prescription opioids annually in the U.S. With this in mind, CDA Public Affairs is sponsoring a course to be held at CDA Presents The Art and Science of Dentistry in San Francisco this August that will help dental professionals understand their role in drug diversion programs, including the use of California’s prescription drug monitoring program known as CURES.
CURES fee exemption available for some dentists
06/22/2017
California prescribers who are registered with the U.S. Drug Enforcement Agency to prescribe, dispense or administer controlled substances must also register to access the state’s prescription drug monitoring program, CURES. A $6 annual ($12 biennial) fee is assessed with licensure renewal in order to maintain the database.
Course helps dentists respond to opioid abuse epidemic
04/18/2017
Dentists prescribe approximately 11 percent of prescription opioids annually in the U.S. A course at CDA Presents in Anaheim will help dental professionals understand the ever-growing problem of prescription drug abuse and dentists' role in drug diversion programs, including the use of California's prescription drug monitoring program known as CURES, Controlled Substance Utilization Review and Evaluation System.
Topics
Search
Enter Keywords
Filter by Date
From :  
To      :